Tel-Array endeavours to transform disease diagnosis from the central laboratory setting to the point-of-care through the development and commercialization of a series of smartphone-integrated, immunoassay-based molecular diagnostic tests and devices. Incorporated and headquartered in Vancouver, British Columbia, Canada, Tel-Array aims to address the increasing need for rapid and low-cost medical diagnoses with its proprietary biosensor technology, coupled with the power of smartphones and cloud-based computing. Its vision is to bring sophisticated medical tests to the point of diagnosis, revolutionizing current medical practices and ultimately ushering in a new era of personalized therapeutics.